Detalles de la búsqueda
1.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Nat Immunol;
23(1): 40-49, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937928
2.
Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).
J Infect Dis;
226(11): 1877-1881, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429382
3.
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people.
Immun Ageing;
18(1): 34, 2021 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34416887
4.
Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
J Infect;
87(5): 403-412, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660754
5.
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes.
Nat Aging;
3(1): 93-104, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118525
6.
Immunological imprinting of humoral immunity to SARS-CoV-2 in children.
Nat Commun;
14(1): 3845, 2023 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386081
7.
The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire.
Blood;
116(16): 2968-74, 2010 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20562332
8.
Extended interval BNT162b2 vaccination enhances peak antibody generation.
NPJ Vaccines;
7(1): 14, 2022 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087066
9.
Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people.
Cell Rep Med;
3(9): 100739, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075216
10.
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
J Hematol Oncol;
15(1): 3, 2022 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000597
11.
Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.
Lancet Healthy Longev;
3(7): e461-e469, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813280
12.
mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273.
Front Immunol;
13: 882515, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720281
13.
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Nat Aging;
2(6): 536-547, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37118449
14.
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis.
Lancet Healthy Longev;
2(9): e554-e560, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34401865
15.
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.
Elife;
102021 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34586068
16.
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.
Lancet Healthy Longev;
2(9): e544-e553, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430954
17.
A role for E1B-AP5 in ATR signaling pathways during adenovirus infection.
J Virol;
82(15): 7640-52, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18480432
18.
Identification of a second CtBP binding site in adenovirus type 5 E1A conserved region 3.
J Virol;
82(17): 8476-86, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18524818
19.
Robust generation of neutralising antibodies against Omicron variants following bivalent mRNA booster vaccine in elderly people aged >80 years.
J Infect;
88(1): 48-50, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37660756
20.
Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia.
Blood Cancer J;
14(1): 22, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38272915